Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H16F3N |
Molecular Weight | 231.2573 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN[C@H](C)CC1=CC(=CC=C1)C(F)(F)F
InChI
InChIKey=DBGIVFWFUFKIQN-SECBINFHSA-N
InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m1/s1
LEVOFENFLURAMINE is a levorotatory enantiomer of fenfluramine, a substituted amphetamine which was formerly used to treat obesity. LEVOFENFLURAMINE has dopamine-antagonistic properties and, at high doses, increases dopamine concentrations in rat striatal dialysates. It is essentially inactive to reduce food intake in human subjects.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats. | 1987 Jul 15 |
|
The effects of D- and L-fenfluramine (and their interactions with D-amphetamine) on psychomotor function and mood. | 1996 Jun |
|
Medicine as a corporate enterprise, patient welfare centered profession, or patient welfare centered professional enterprise? | 2005 Nov |
|
Off-label promotion, on-target sales. | 2008 Oct 28 |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
1670
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3616-77-1
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
SUPERSEDED | |||
|
37577-24-5
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
DTXSID60191009
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
C175112
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
521051
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
SUB08470MIG
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
Levofenfluramine
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
6132
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
953A94Y45B
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
65801
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
100000082295
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | |||
|
m5274
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL438145
Created by
admin on Fri Dec 15 18:51:58 GMT 2023 , Edited by admin on Fri Dec 15 18:51:58 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)